These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2203926)

  • 21. [Blood platelets and ischemic heart disease and myocardial infarction].
    Gebalska J
    Kardiol Pol; 1991; 35(9):191-6. PubMed ID: 1753567
    [No Abstract]   [Full Text] [Related]  

  • 22. beta-Amyloid protein induces platelet aggregation and supports platelet adhesion.
    Kowalska MA; Badellino K
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1829-35. PubMed ID: 7811271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine diphosphate induced platelet aggregation in myocardial infarction and ischemic heart disease.
    Dreyfuss F; Zahavi J
    Atherosclerosis; 1973; 17(1):107-20. PubMed ID: 4696737
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP.
    Michal F; Motamed M
    Br J Pharmacol; 1975 Jun; 54(2):221P-222P. PubMed ID: 1148513
    [No Abstract]   [Full Text] [Related]  

  • 26. [Platelet aggregation in patients with coronary disease treated with nifedipine].
    Tkaczewski W; Goch JH; Kruszyński G; Ryniec A
    Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):219-21. PubMed ID: 2216944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of platelet adhesion and aggregation: an update.
    Bennett JS
    Hosp Pract (Off Ed); 1992 Apr; 27(4):124-6, 129-30, 133-8 passim. PubMed ID: 1313821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of adhesive proteins and membrane interactions in the processes of thrombocyte aggregation].
    Belitser NV; Anishchuk MG; Pozdniakova TM; Gorkun OV; Veklich VI; Smekhova TR
    Vestn Akad Med Nauk SSSR; 1991; (10):45-50. PubMed ID: 1801463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flush release of ADP from erythrocytes as a cause of platelet aggregation in glass bead column method.
    Hattori A; Tsukada T; Yamamoto M; Matsuoka M; Odajima H
    Nihon Ketsueki Gakkai Zasshi; 1974 Jun; 37(3):293-5. PubMed ID: 4479919
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target.
    Straub A; Krajewski S; Hohmann JD; Westein E; Jia F; Bassler N; Selan C; Kurz J; Wendel HP; Dezfouli S; Yuan Y; Nandurkar H; Jackson S; Hickey MJ; Peter K
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1607-16. PubMed ID: 21512161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-platelet drugs: rationale for use.
    Hardisty RM
    Bibl Haematol; 1977; 44():181-7. PubMed ID: 216344
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antiplatelet therapy and platelet function studies in elderly patients with ischemic heart disease--evaluation of whole blood platelet aggregation].
    Kawamura H; Kodama H; Takeuchi G; Kohsaka K; Suzuki S; Nitta M; Takada K; Mitomo Y; Yamamoto M
    Rinsho Ketsueki; 1986 Oct; 27(10):1815-22. PubMed ID: 3820607
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical aspects of control in therapy with platelet inhibitors].
    Bokarev IN; Ovcinnikova LV; Aleksandrova NA; Kabaeva EV; Marcukova EV; Kun IS; Olbinskaja LI
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):776-82. PubMed ID: 94869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelets in atherothrombosis.
    Vorchheimer DA; Becker R
    Mayo Clin Proc; 2006 Jan; 81(1):59-68. PubMed ID: 16438480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adhesion of ADP-activated platelets to intact endothelium under stagnation point flow in vitro is mediated by the integrin alphaIIbeta3.
    Reininger AJ; Korndörfer MA; Wurzinger LJ
    Thromb Haemost; 1998 May; 79(5):998-1003. PubMed ID: 9609236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental basis of platelet aggregation inhibition by acetylsalicylic acid.
    Born GV; Görög P; Begent NA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):719-24. PubMed ID: 6083947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial: Much hope but little proof.
    Danilevicius Z
    JAMA; 1976 Oct; 236(14):1613. PubMed ID: 989140
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of dilazep on platelet aggregation.
    Nakajima K; Shirai K; Takimoto M; Satoh F; Aoki M
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1899-901. PubMed ID: 4480271
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrombosis in arteries: mechanisms and prevention.
    Born GV
    Verh K Acad Geneeskd Belg; 1980; 42(3-4):157-63. PubMed ID: 7257560
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of high concentrations of glucose on thrombocyte aggregation].
    Lisovskaia IL; Volkova RI; Markosian RA
    Biull Eksp Biol Med; 1974 Oct; 78(10):24-7. PubMed ID: 4461114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.